Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 3 out of 24 pages
Exam (elaborations)

NR507 ADVANCED PATHOPHYSIOLOGY FINAL EXAM PREP QUESTIONS AND ANSWERS

Document preview thumbnail
Preview 3 out of 24 pages

NR507 ADVANCED PATHOPHYSIOLOGY FINAL EXAM PREP QUESTIONS AND ANSWERS

Content preview

NR507 ADVANCED
PATHOPHYSIOLOGY FINAL EXAM
PREP QUESTIONS AND ANSWERS



1. Which cellular adaptation involves an increase in the number of cells in an organ or tissue?

A. Hypertrophy


B. Atrophy


C. Hyperplasia


D. Metaplasia


Answer: C


Conceptual Explanation: Hyperplasia is an increase in the number of cells resulting from

an increased rate of cellular division. Hypertrophy is an increase in the size of cells.


2. Which type of cell death is characterized by ‘programmed cell death’ and does not typically

trigger an inflammatory response?

A. Apoptosis


B. Necrosis


C. Autophagy


D. Infarction

,Answer: A


Conceptual Explanation: Apoptosis is a distinct type of programmed cell death that

occurs in both physiological and pathological conditions, without causing inflammation.


3. A patient presents with a chromosomal abnormality characterized by the presence of three

copies of chromosome 21. This condition is known as:

A. Turner Syndrome


B. Klinefelter Syndrome


C. Edward Syndrome


D. Down Syndrome


Answer: D


Conceptual Explanation: Down Syndrome is caused by trisomy 21, meaning there are

three copies of chromosome 21 instead of the usual two.


4. In Type I Hypersensitivity reactions, which antibody is primarily responsible for the allergic

response?

A. IgG


B. IgM


C. IgA


D. IgE


Answer: D

, Conceptual Explanation: Type I hypersensitivity is mediated by IgE antibodies which bind

to mast cells, leading to degranulation and release of histamine.


5. Which of the following is a systemic autoimmune disease characterized by the production

of antinuclear antibodies (ANAs)?

A. Systemic Lupus Erythematosus


B. Rheumatoid Arthritis


C. Type 1 Diabetes Mellitus


D. Hashimoto Thyroiditis


Answer: A


Conceptual Explanation: Systemic Lupus Erythematosus (SLE) is a chronic multisystem

inflammatory disease involving the production of antibodies against self-antigens,

including DNA and other nuclear components.


6. The primary target cell for the Human Immunodeficiency Virus (HIV) is:

A. CD8+ T cells


B. B lymphocytes


C. CD4+ T cells


D. Natural Killer cells


Answer: C

Document information

Uploaded on
July 29, 2026
Number of pages
24
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$15.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
Fyndlay
3.6
(76)
Sold
422
Followers
81
Items
20241
Last sold
3 days ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions